MiLaboratories

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://milaboratories.com/

Last Round

Series A

Oct 10, 2024

Est. Valuation

$39.5M

Total Funding Raised

$12.3M

Company Overview

MiLaboratories is a biotechnology company that develops advanced bioinformatics software and computational platforms for the analysis of immune repertoire sequencing data to accelerate drug discovery and personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Usage-Based SaaS, Hardware Sales, Marketplace Commission, Services & Consulting

AI Layer

Application

Keywords

immune repertoire profilingcomputational biology platformNGS data analysisimmunosequencingnext-generation sequencingNGSbioinformatics softwareimmunoinformaticsantibody discoveryTCR sequencing analysisBCR sequencing analysisdrug discoveryvaccine developmentcancer researchbioinformatics SDKfreemium SaaSimmunosequencing kits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MiLaboratories Comps

Public and private peers based on sector, stage, and business model.

MiLaboratories comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MiLaboratories Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 10, 2024
Seed	Feb 22, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Dmitriy Bolotin

Chief Technology Officer, Co-founder

Founding Team

Stanislav Poslavsky

Chief Executive Officer, Co-founder

Founding Team

Roberto Gomez Ledesma

COO

Executive Team

MiLaboratories Investors

Notable investors and investment history

MiLaboratories investors
Investor	Rounds
Acrobator Ventures	Series A, Seed
Kfund	Series A
Acrobator	Series A
Courtyard Ventures	Series A
EGB Capital	Series A
Speedinvest	Series A, Seed
K Fund	Series A

View all Investors

MiLaboratories Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MiLaboratories Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MiLaboratories's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range26

Year Founded2013

Last FundingOct 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.